Journal of Literature Pharmacy Sciences

Biyouyumlu ve Biyobozunur Doğal Bir Polimer Olan Kitosan ve Kitosanın Diş Hekimliğinde Remineralizasyon Ajanı Olarak Kullanıldığı İlaç Taşıyıcı Sistemler: Geleneksel Derleme
Chitosan, a Natural Biocompatible and Biodegradable Polymer, and Drug Delivery Systems Where Chitosan is Used As a Remineralization Agent in Dentistry: Traditional Review
A. Alper ÖZTÜRKa, Sedef ARSLANb
aAnadolu Üniversitesi Eczacılık Fakültesi, Farmasötik Teknoloji ABD, Eskişehir, Türkiye
bSerbest Diş Hekimi, Eskişehir, Türkiye
J Lit Pharm Sci. 2023;12(2):143-56
doi: 10.5336/pharmsci.2022-94919
Article Language: TR
Full Text
ÖZET
 Kitosan, farmasötik alanda üzerinde en çok çalışılan biyomateryallerden biridir. Biyobozunurluk, düşük toksisite, iyi biyouyumluluk, vücutta birikme riskinin bulunmaması, mukoadezivlik, antioksidan, antibakteriyel, antifungal, yara iyileştirici, hemostatik, antiinflamatuar ve antikanser gibi özellikler, kitosanı biyomedikal alanda ve farmasötik formülasyonlarda kullanıma uygun hâle getirmektedir. Kitosanın diş hekimliğinin farklı alanlarında etkinliği kanıtlanmış tedavi amaçlı kullanımı bulunmakla beraber, kitosan ve türevlerinin, koruyucu diş hekimliğinde ve doku mühendisliğinde remineralizasyon sürecini teşvik etmede yaygın olarak kullanılmaktadır ve bu konu hakkında çalışmalar in vitro ve in vivo olarak devam etmektedir. Remineralizasyon, hidroksiapatit formundaki mineral kazancının diş yapısına kazandırılması işlemidir. Remineralizasyon ajanları, erken lezyon çevresinde aşırı doymuş bir ortam yaratır; böylece mineral kaybını önler ve boş alanlara kalsiyum ve fosfat iyonlarının geçmesini sağlar. Dünya genelinde optimum diş bakımı sağlamak, ağız ve diş hastalıklarını tedavi etmek ülke ekonomilerinde oldukça büyük bir paya sahiptir. Ağız/diş hastalıklarının tedavisi, hem ağız hem genel sağlık hem de ülke ekonomileri için faydalıdır. Literatür incelendiğinde, geleneksel tedavi yaklaşımlarından uzaklaşıp yeni nanofarmasötikler gibi yeni ilaç taşıyıcı sistemler üzerinde yoğunlaşılmıştır. Bu derleme kapsamında, öncelikle demineralizasyon, remineralizasyon mekanizmaları hakkında bilgi verilmiş olup, ardından kitosanın remineralizasyon mekanizması açıklanmıştır. Derlemenin son bölümünde ise kitosanın diş hekimliğinde remineralizasyon ajanı olarak kullanıldığı geleneksel ve modern ilaç taşıyıcı sistemlerden bahsedilmiştir. Bu derlemenin ilaç taşıyıcı sistemler, kitosan ve remineralizasyon hakkında araştırma & geliştirme çalışmalarında bulunan diş hekimleri ve eczacılara, aynı zamanda klinisyenlere görüş sunacağı düşünülmektedir.

Anahtar Kelimeler: Kitosan; ilaç taşıyıcı sistemler; demineralizasyon; remineralizasyon; nanopartikül
ABSTRACT
 Chitosan is one of the most studied biomaterials in the pharmaceutical field. Biodegradability, low toxicity, good biocompatibility, no risk of accumulation in the body, mucoadhesiveness, antioxidant, antibacterial, antifungal, wound healing, hemostatic, antiinflammatory and anticancer properties make chitosan suitable for use in the biomedical field and pharmaceutical formulations. Although chitosan has proven therapeutic use in different fields of dentistry, chitosan and its derivatives are widely used to promote the remineralization process in preventive dentistry and tissue engineering, and studies on this subject continue in vitro and in vivo. Remineralization is the process of giving the mineral gain in the form of hydroxyapatite to the tooth structure. Remineralizing agents create a supersaturated environment around the early lesion; thus preventing mineral loss and allowing calcium and phosphate ions to pass into empty spaces. Providing optimum dental care and treating oral and dental diseases around the world has a large share in the national economy. The treatment of oral/dental diseases is beneficial for both oral and general health and national economies. When the literature is examined, it has moved away from traditional treatment approaches and focused on new drug delivery systems such as new nanopharmaceuticals. Within the scope of this review, firstly, information about demineralization and remineralization mechanisms is given, and then the remineralization mechanism of chitosan is explained. In the last part of the review, traditional and modern drug delivery systems in which chitosan is used as a remineralization agent in dentistry are mentioned. It is thought that this review will provide opinions to dentists and pharmacists who are involved in research & development studies on drug delivery systems, chitosan and remineralization, as well as clinicians.

Keywords: Chitosan; drug delivery systems; demineralization; remineralization; nanoparticle
REFERENCES:
  1. Gao H, Wu N, Wang N, Li J, Sun J, Peng Q. Chitosan-based therapeutic systems and their potentials in treatment of oral diseases. Int J Biol Macromol. 2022;222(Pt B):3178-94. [Crossref]  [PubMed] 
  2. Spanemberg JC, Cardoso JA, Slob EMGB, López-López J. Quality of life related to oral health and its impact in adults. J Stomatol Oral Maxillofac Surg. 2019;120(3):234-9. [Crossref]  [PubMed] 
  3. Scannapieco FA, Cantos A. Oral inflammation and infection, and chronic medical diseases: implications for the elderly. Periodontol 2000. 2016;72(1):153-75. [Crossref]  [PubMed] 
  4. Kazemi-Karyani A, Yahyavi Dizaj J, Khoramrooz M, Soltani S, Soofi M, Irandoust K, et al. Socio-economic inequality in reported dental self-care behaviour among Iranian households: a national pooled study. Int J Dent Hyg. 2022;20(4):689-99. [Crossref]  [PubMed] 
  5. Koşar Ş, Ekinci M, Öztürk AA. Cilt tipleri ve ihtiyaçlara göre dermakozmetik ürün önerilmesinde eczacının rolü ve nanokozmetikler: geleneksel derleme [The role of pharmacist in consulting dermacosmetic products according to skin types and needs and nanocosmetics: traditional review]. J Lit Pharm Sci. 2022;11(2):119-35. [Crossref] 
  6. Sharifianjazi F, Khaksar S, Esmaeilkhanian A, Bazli L, Eskandarinezhad S, Salahshour P, et al. Advancements in fabrication and application of chitosan composites in implants and dentistry: a review. Biomolecules. 2022;12(2):155. [Crossref]  [PubMed]  [PMC] 
  7. Öztürk AA, Kıyan HT. Treatment of oxidative stress-induced pain and inflammation with dexketoprofen trometamol loaded different molecular weight chitosan nanoparticles: Formulation, characterization and anti-inflammatory activity by using in vivo HET-CAM assay. Microvasc Res. 2020;128:103961. [Crossref]  [PubMed] 
  8. Prashanth KH, Tharanathan R. Chitin/chitosan: modifications and their unlimited application potential-an overview. Trends Food Sci Technol. 2007;18(3):117-31. [Crossref] 
  9. Yang HC, Hon MH. The effect of the molecular weight of chitosan nanoparticles and its application on drug delivery. Microchem J. 2009;92(1):87-91. [Crossref] 
  10. Saikia C, Gogoi P, Maji T. Chitosan: a promising biopolymer in drug delivery applications. J Mol Genet Med S. 2015;4(006):899-910. [Crossref] 
  11. Fakhri E, Eslami H, Maroufi P, Pakdel F, Taghizadeh S, Ganbarov K, et al. Chitosan biomaterials application in dentistry. Int J Biol Macromol. 2020;162:956-74. [Crossref]  [PubMed] 
  12. Ozlek E, Rath PP, Kishen A, Neelakantan P. A chitosan-based irrigant improves the dislocation resistance of a mineral trioxide aggregate-resin hybrid root canal sealer. Clin Oral Investig. 2020;24(1):151-6. [Crossref]  [PubMed] 
  13. Islam MM, Shahruzzaman M, Biswas S, Sakib MN, Rashid TU. Chitosan based bioactive materials in tissue engineering applications-a review. Bioact Mater. 2020;5(1):164-83. [Crossref]  [PubMed]  [PMC] 
  14. de Melo CCDSB, Cassiano FB, Bronze-Uhle ÉS, Stuani VT, Bordini EAF, Gallinari MO, et al. Mineral-induced bubbling effect and biomineralization as strategies to create highly porous and bioactive scaffolds for dentin tissue engineering. J Biomed Mater Res B Appl Biomater. 2022;110(8):1757-70. [Crossref]  [PubMed] 
  15. Ngwabebhoh FA, Zandraa O, Patwa R, Saha N, Capáková Z, Saha P. Self-crosslinked chitosan/dialdehyde xanthan gum blended hypromellose hydrogel for the controlled delivery of ampicillin, minocycline and rifampicin. Int J Biol Macromol. 2021;167:1468-78. [Crossref]  [PubMed] 
  16. Goldberg M, Manzi A, Birdi A, Laporte B, Conway P, Cantin S, et al. A nanoengineered topical transmucosal cisplatin delivery system induces anti-tumor response in animal models and patients with oral cancer. Nat Commun. 2022;13(1):4829. Erratum in: Nat Commun. 2022;13(1):7865. [Crossref]  [PubMed]  [PMC] 
  17. Moeini A, Pedram P, Makvandi P, Malinconico M, Gomez d'Ayala G. Wound healing and antimicrobial effect of active secondary metabolites in chitosan-based wound dressings: a review. Carbohydr Polym. 2020;233:115839. [Crossref]  [PubMed] 
  18. Campos JC, Ferreira DC, Lima S, Reis S, Costa PJ. Swellable polymeric particles for the local delivery of budesonide in oral mucositis. Int J Pharm. 2019;566:126-40. [Crossref]  [PubMed] 
  19. Erpaçal B, Adıgüzel Ö, Cangül S, Acartürk M. A general overview of chitosan and its use in dentistry. International Biological and Biomedical Journal. 2019;5(1):1-11. [Link] 
  20. Hallmann L, Gerngroß MD. Chitosan and its application in dental implantology. J Stomatol Oral Maxillofac Surg. 2022;123(6):e701-7. [Crossref]  [PubMed] 
  21. Sreenivasalu PKP, Dora CP, Swami R, Jasthi VC, Shiroorkar PN, Nagaraja S, et al. Nanomaterials in dentistry: current applications and future scope. Nanomaterials (Basel). 2022;12(10):1676. [Crossref]  [PubMed]  [PMC] 
  22. Huang SB, Gao SS, Yu HY. Effect of nano-hydroxyapatite concentration on remineralization of initial enamel lesion in vitro. Biomed Mater. 2009;4(3):034104. [Crossref]  [PubMed] 
  23. Li X, Wang J, Joiner A, Chang J. The remineralisation of enamel: a review of the literature. J Dent. 2014;42 Suppl 1:S12-20. [Crossref]  [PubMed] 
  24. Öztürk AA, Arslan S. Dental Tedaviler ve Koruyucu Diş Hekimliğinde Önemli Bir Yere Sahip Remineralizasyon Ajanları ve Nanofarmasötik Yaklaşımlar: Geleneksel Derleme. J lit Pharm Sci. 2023;12(1):92-100. [Crossref] 
  25. He J, Bao Y, Li J, Qiu Z, Liu Y, Zhang X. Nanocomplexes of carboxymethyl chitosan/amorphous calcium phosphate reduce oral bacteria adherence and biofilm formation on human enamel surface. J Dent. 2019;80:15-22. [Crossref]  [PubMed] 
  26. Balakrishnan A, Jonathan R, Benin P, Kuumar A. Evaluation to determine the caries remineralization potential of three dentifrices: an in vitro study. J Conserv Dent. 2013;16(4):375-9. [Crossref]  [PubMed]  [PMC] 
  27. Featherstone JD. The continuum of dental caries--evidence for a dynamic disease process. J Dent Res. 2004;83 Spec No C:C39-42. [Crossref]  [PubMed] 
  28. Fernando JR, Walker GD, Park TK, Shen P, Yuan Y, Reynolds C, et al. Comparison of calcium-based technologies to remineralise enamel subsurface lesions using microradiography and microhardness. Sci Rep. 2022;12(1):9888. [Crossref]  [PubMed]  [PMC] 
  29. Featherstone JD. Remineralization, the natural caries repair process--the need for new approaches. Adv Dent Res. 2009;21(1):4-7. [Crossref]  [PubMed] 
  30. Philip N. State of the art enamel remineralization systems: the next frontier in caries management. Caries Res. 2019;53(3):284-95. [Crossref]  [PubMed]  [PMC] 
  31. Cochrane NJ, Cai F, Huq NL, Burrow MF, Reynolds EC. New approaches to enhanced remineralization of tooth enamel. J Dent Res. 2010;89(11):1187-97. [Crossref]  [PubMed] 
  32. Arnaud TM, de Barros Neto B, Diniz FB. Chitosan effect on dental enamel de-remineralization: an in vitro evaluation. J Dent. 2010;38(11):848-52. [Crossref]  [PubMed] 
  33. Ekinci M, Öztürk AA, İlem-Özdemir D. Preparation, radiolabeling and cell culture studies of chitosan coated PLGA nanoparticles as a potential cancer diagnostic agent. J Res Pharm. 2022;26(6):1636-45. [Link] 
  34. Chen P, Liu L, Pan J, Mei J, Li C, Zheng Y. Biomimetic composite scaffold of hydroxyapatite/gelatin-chitosan core-shell nanofibers for bone tissue engineering. Mater Sci Eng C Mater Biol Appl. 2019;97:325-35. [Crossref]  [PubMed] 
  35. Aimoli CG, Torres MA, Beppu MM. Investigations into the early stages of "in vitro" calcification on chitosan films. Mater Sci Eng C. 2006;26(1):78-86. [Crossref] 
  36. Baskar D, Balu R, Kumar TS. Mineralization of pristine chitosan film through biomimetic process. Int J Biol Macromol. 2011;49(3):385-9. [Crossref]  [PubMed] 
  37. Zhang J, Lynch RJM, Watson TF, Banerjee A. Chitosan-bioglass complexes promote subsurface remineralisation of incipient human carious enamel lesions. J Dent. 2019;84:67-75. [Crossref]  [PubMed] 
  38. Ibrahim HM, Reda MM, Klingner A. Preparation and characterization of green carboxymethylchitosan (CMCS) - Polyvinyl alcohol (PVA) electrospun nanofibers containing gold nanoparticles (AuNPs) and its potential use as biomaterials. Int J Biol Macromol. 2020;151:821-9. [Crossref]  [PubMed] 
  39. Zhang X, Li Y, Sun X, Kishen A, Deng X, Yang X, et al. Biomimetic remineralization of demineralized enamel with nano-complexes of phosphorylated chitosan and amorphous calcium phosphate. J Mater Sci Mater Med. 2014;25(12):2619-28. [Crossref]  [PubMed] 
  40. Nimbeni SB, Nimbeni BS, Divakar DD. Role of chitosan in remineralization of enamel and dentin: a systematic review. Int J Clin Pediatr Dent. 2021;14(4):562-8. [Crossref]  [PubMed]  [PMC] 
  41. Öztürk AA, Yenilmez E. Pharmacological and pharmaceutical technological overview for seborrheic dermatitis: A review about topical application and new approaches. ACTA Pharm Sci. 2018;56(4):57-80. [Crossref] 
  42. Ibrahim IE, Karam SS, Aly HM. Biomimetic enamel remineralization using chitosan hydrogel (an in vitro study). Alex Dent J. 2018;43(3):116-21. [Crossref] 
  43. Meshki R, Basir L, Rahbar N, Kazempour M. Comparison of the effect of fluoride gel and two toothpastes with different materials on remineralization of initial carious lesions in primary teeth. J Family Med Prim Care. 2021;10(9):3309-13. [Crossref]  [PubMed]  [PMC] 
  44. Desouky NR, El-Gany A, Mostafa M, Adawy HA, Ahmed NA. Comparison between chitosan hydrogel and recaldent paste in enamel re-mineralization of induced enamel demineralized lesions. ADJG. 2022;9(2):311-20. [Crossref] 
  45. Sadik MH, Jamil WE, Mosleh AA. Comparative study on the remineralizing and antimicrobial effect of naturally and synthetically based agents. ADJG. 2022;9(3):451-9. [Crossref] 
  46. Reis FN, Francese MM, Silva NDGD, Pelá VT, Câmara JVF, Trevizol JS, et al. Gels containing statherin-derived peptide protect against enamel and dentin erosive tooth wear in vitro. J Mech Behav Biomed Mater. 2023;137:105549. [Crossref]  [PubMed] 
  47. Simeonov M, Gussiyska A, Mironova J, Nikolova D, Apostolov A, Sezanova K, et al. Novel hybrid chitosan/calcium phosphates microgels for remineralization of demineralized enamel-a model study. Eur Polym J. 2019;119:14-21. [Crossref] 
  48. Santoso T, Djauharie NK, Ahdi W, Latief FDE, Suprastiwi E. Carboxymethyl chitosan/amorphous calcium phosphate and dentin remineralization. J Int Dent Med Res. 2019;12(1):84-7. [Link] 
  49. Annisa RN, Djauharie N, Suprastiwi E, Avanti N. The effect of carboxymethyl chitosan/amorphous calcium phosphate to guide tissue remineralization of dentin collagen. Int J App Pharma. 2019;11:181-3. [Crossref] 
  50. Ren Q, Li Z, Ding L, Wang X, Niu Y, Qin X, et al. Anti-biofilm and remineralization effects of chitosan hydrogel containing amelogenin-derived peptide on initial caries lesions. Regen Biomater. 2018;5(2):69-76. [Crossref]  [PubMed]  [PMC] 
  51. Uysal T, Akkurt MD, Amasyali M, Ozcan S, Yagci A, Basak F, et al. Does a chitosan-containing dentifrice prevent demineralization around orthodontic brackets? Angle Orthod. 2011;81(2):319-25. [Crossref]  [PubMed]  [PMC] 
  52. Basir L, Meshki R, Aghababa H, Rakhshan V. Effects of three commercial toothpastes incorporating "chitosan, casein phosphopeptide-amorphous calcium phosphate, sodium monofluorophosphate, and sodium fluoride" on remineralization of incipient enamel caries in the primary dentition: a preliminary in vitro study. Dent Res J (Isfahan). 2020;17(6):433-8. [Crossref]  [PubMed]  [PMC] 
  53. Ruan Q, Siddiqah N, Li X, Nutt S, Moradian-Oldak J. Amelogenin-chitosan matrix for human enamel regrowth: effects of viscosity and supersaturation degree. Connect Tissue Res. 2014;55 Suppl 1(0 1):150-4. [Crossref]  [PubMed]  [PMC] 
  54. Xu Z, Neoh KG, Lin CC, Kishen A. Biomimetic deposition of calcium phosphate minerals on the surface of partially demineralized dentine modified with phosphorylated chitosan. J Biomed Mater Res B Appl Biomater. 2011;98(1):150-9. [Crossref]  [PubMed] 
  55. Ekinci M, Öztürk AA, Santos-Oliveira R, İlem-Özdemir D. The use of Lamivudine-loaded PLGA nanoparticles in the diagnosis of lung cancer: preparation, characterization, radiolabeling with 99mTc and cell binding. J Drug Deliv Sci Tech. 2022;69:103139. [Crossref] 
  56. Öztürk AA, Yenilmez E, Arslan R, Şenel B, Yazan Y. Dexketoprofen trometamol loaded solid lipid nanoparticles (SLNs): formulation, in vitro and in vivo evaluation. J Res Pharm. 2020;24(1):82-99. [Crossref] 
  57. Öztürk AA, Namlı İ, Güleç K, Görgülü Ş. Design of lamivudine loaded nanoparticles for oral application by nano spray drying method: a new approach to use an antiretroviral drug for lung cancer treatment. Comb Chem High Throughput Screen. 2020;23(10):1064-79. [Crossref]  [PubMed] 
  58. Quintanar‐Guerrero D, Leyva‐Gómez G, Vergara NEM, Mu-oz NM. Nanopharmaceuticals. Nanomaterials and Nanotechnology in Medicine. 2022:87-114. [Crossref] 
  59. Gangapure SP, Bhusnure OG. Nanopharmaceuticals. Journal of Drug Delivery and Therapeutics. 2019:9(4):676-87. [Link] 
  60. Sayıner Ö, Çomoğlu T. Nanotaşıyıcı sistemlerde hedeflendirme [Targeting with nanocarrier systems]. J Fac Pharm Ankara. 2016;40(3):62-79. [Crossref] 
  61. Bapat RA, Joshi CP, Bapat P, Chaubal TV, Pandurangappa R, Jnanendrappa N, et al. The use of nanoparticles as biomaterials in dentistry. Drug Discov Today. 2019;24(1):85-98. [Crossref]  [PubMed] 
  62. Jain P, Dilnawaz F, Iqbal Z. Insights into nanotools for dental interventions. In: Yata VK, Ranjan S, Dasgupta N, Lichtfouse E, eds. Nanopharmaceuticals: Principles and Applications. Vol 3. 1st ed. Cham: Springer, Natura; 2020. p.53-79. [Crossref] 
  63. Narang RS, Narang JK. Nanomedicines for dental applications-scope and future perspective. Int J Pharm Investig. 2015;5(3):121-3. [Crossref]  [PubMed]  [PMC] 
  64. Ghods K, Akbari P, Dehghani Ashkezari P, Ghayoomi S. Newest developments of nanotechnology in dentistry: a review of literature. Journal of Dental Materials and Techniques. 2022;11(1):1-10. [Crossref] 
  65. Zhu N, Chatzistavrou X, Ge L, Qin M, Papagerakis P, Wang Y. Biological properties of modified bioactive glass on dental pulp cells. J Dent. 2019;83:18-26. [Crossref]  [PubMed] 
  66. Magalhães TC, Teixeira NM, França RS, Denadai ÂML, Santos RLD, Carlo HL, et al. Synthesis of a chitosan nanoparticle suspension and its protective effects against enamel demineralization after an in vitro cariogenic challenge. J Appl Oral Sci. 2021;29:e20210120. [Crossref]  [PubMed]  [PMC] 
  67. Nguyen S, Escudero C, Sediqi N, Smistad G, Hiorth M. Fluoride loaded polymeric nanoparticles for dental delivery. Eur J Pharm Sci. 2017;104:326-34. [Crossref]  [PubMed] 
  68. Wassel MO, Sherief DI. Ion release and enamel remineralizing potential of miswak, propolis and chitosan nano-particles based dental varnishes. Pediatr Dent J. 2019;29(1):1-10. [Crossref] 
  69. Xiao Z, Que K, Wang H, An R, Chen Z, Qiu Z, et al. Rapid biomimetic remineralization of the demineralized enamel surface using nano-particles of amorphous calcium phosphate guided by chimaeric peptides. Dent Mater. 2017;33(11):1217-28. [Crossref]  [PubMed] 
  70. Uskoković V, Abuna G, Ferreira P, Wu VM, Gower L, Pires-de-Souza FCP, et al. Synthesis and characterization of nanoparticulate niobium-and zinc-doped bioglass-ceramic/chitosan hybrids for dental applications. J Sol-Gel Sci Technol. 2021;97:245-58. [Crossref] 
  71. Hood MA, Landfester K, Munoz-Espi R. Chitosan nanoparticles affect polymorph selection in crystallization of calcium carbonate. Colloids Surf A Physicochem Eng Asp. 2018;540:48-52. [Crossref] 
  72. Domingo C, Saurina J. An overview of the analytical characterization of nanostructured drug delivery systems: towards green and sustainable pharmaceuticals: a review. Anal Chim Acta. 2012;744:8-22. [Crossref]  [PubMed] 
  73. Marangoz Ö, Yavuz O. Nano-ilaç taşıma sistemleri ve toksikolojik değerlendirmeleri [Nano-drug delivery systems and their toxicological assessment]. Turkish Bulletin of Hygiene & Experimental Biology. 2020;77(4):509-26. [Crossref] 
  74. Saiyed MA, Patel RC, Patel SC. Toxicology perspective of nanopharmaceuticals: a critical review. Int J Pharm Sci Nanotechnol. 2011;4(1):1287-95. [Crossref] 
  75. Pasumarthi S, Nagabhushanam MV, Reddy DN, Brahmaiah B. Nanomedicine clinical use, regulatory and toxicology issues in Europe. Journal of Drug Delivery and Therapeutics. 2019;9(4-s):846-8. [Crossref] 

.: Up To Date

.: Process List

Login

 Forgot your password?

 New Registration  

Contact

Ortadoğu Reklam Tanıtım Yayıncılık Turizm Eğitim İnşaat Sanayi ve Ticaret A.Ş.

.: Address

Turkocagi Caddesi No:30 06520 Balgat / ANKARA
Phone: +90 312 286 56 56
Fax: +90 312 220 04 70
E-mail: info@turkiyeklinikleri.com

.: Manuscript Editing Department

Phone: +90 312 286 56 56/ 2
E-mail: yaziisleri@turkiyeklinikleri.com

.: English Language Redaction

Phone: +90 312 286 56 56/ 145
E-mail: tkyayindestek@turkiyeklinikleri.com

.: Marketing Sales-Project Department

Phone: +90 312 286 56 56/ 142
E-mail: reklam@turkiyeklinikleri.com

.: Subscription and Public Relations Department

Phone: +90 312 286 56 56/ 118
E-mail: abone@turkiyeklinikleri.com

.: Customer Services

Phone: +90 312 286 56 56/ 118
E-mail: satisdestek@turkiyeklinikleri.com

1. TERMS OF USE

1.1. To use the web pages with http://www.turkiyeklinikleri.com domain name or the websites reached through the sub domain names attached to the domain name (They will be collectively referred as "SITE"), please read the conditions below. If you do not accept these terms, please cease to use the "SITE." "SITE" owner reserves the right to change the information on the website, forms, contents, the "SITE," "SITE" terms of use anytime they want.

1.2. The owner of the "SITE" is Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. (From now on it is going to be referred as "Turkiye Klinikleri", shortly) and it resides at Turkocagi cad. No:30, 06520 Balgat Ankara. The services in the "SITE" are provided by "Turkiye Klinikleri."

1.3. Anyone accessing the "SITE" with or without a fee whether they are a natural person or a legal identity is considered to agree these terms of use. In this contract hereby, "Turkiye Klinikleri" may change the stated terms anytime. These changes will be published in the "SITE" periodically and they will be valid when they are published. Any natural person or legal identity benefiting from and reaching to the "SITE" are considered to be agreed to any change on hereby contract terms done by "Turkiye Klinikleri."

1.4. The "Terms of Use" hereby is published in the website with the last change on March 30th 2014 and the "SITE" is activated by enabling the access to everyone. The "Terms of Use" hereby is also a part of the any "USER Contract" was and/or will be done with the users using "Turkiye Klinikleri" services with or without a fee an inseparable.

2. DEFINITIONS

2.1. "SITE": A website offering different kind of services and context with a certain frame determined by "Turkiye Klinikleri" and it is accessible on-line on http://www.turkiyeklinikleri.com domain name and/or subdomains connected to the domain name.

2.2. USER: A natural person or a legal identity accessing to the "SITE" through online settings.

2.3. LINK: A link enabling to access to another website through the "SITE", the files, the context or through another website to the "SITE", the files and the context.

2.4. CONTEXT: Any visual, literary and auditory images published in the "Turkiye Klinikleri", "SITE" and/or any website or any accessible information, file, picture, number/figures, price, etc.

2.5. "USER CONTRACT": An electronically signed contract between a natural or a legal identity benefiting from special services "Turkiye Klinikleri" will provide and "Turkiye Klinikleri".

3. SCOPE OF THE SERVICES

3.1. "Turkiye Klinikleri" is completely free to determine the scope and quality of the services via the "SITE".

3.2. To benefit the services of "Turkiye Klinikleri" "SITE", the "USER" must deliver the features that will be specified by "Turkiye Klinikleri". "Turkiye Klinikleri" may change this necessity any time single-sided.

3.3. Not for a limited number, the services "Turkiye Klinikleri" will provide through the "SITE" for a certain price or for free are;

- Providing scientific articles, books and informative publications for health industry.

- Providing structural, statistical and editorial support to article preparation stage for scientific journals.

4. GENERAL PROVISIONS

4.1. "Turkiye Klinikleri" is completely free to determine which of the services and contents provided in the "SITE" will be charged.

4.2. People benefiting from the services provided by "Turkiye Klinikleri" and using the website can use the "SITE" only according to the law and only for personal reasons. Users have the criminal and civil liability for every process and action they take in the "SITE". Every USER agrees, declares and undertakes that they will not proceed by any function or action infringement of rights of "Turkiye Klinikleri"s and/or other third parties', they are the exclusive right holder on usage, processing, storage, made public and revealing any written, visual or auditory information reported to Turkiye Klinikleri" and/or "SITE" to the third parties. "USER" agrees and undertakes that s/he will not duplicate, copy, distribute, process, the pictures, text, visual and auditory images, video clips, files, databases, catalogs and lists within the "SITE", s/he will not be using these actions or with other ways to compete with "Turkiye Klinikleri", directly or indirectly.

4.3. The services provided and the context published within the "SITE" by third parties is not under the responsibility of "Turkiye Klinikleri", institutions collaborated with "Turkiye Klinikleri", "Turkiye Klinikleri" employee and directors, "Turkiye Klinikleri" authorized salespeople. Commitment to accuracy and legality of the published information, context, visual and auditory images provided by any third party are under the full responsibility of the third party. "Turkiye Klinikleri" does not promise and guarantee the safety, accuracy and legality of the services and context provided by a third party.

4.4. "USER"s cannot act against "Turkiye Klinikleri", other "USER"s and third parties by using the "SITE". "Turkiye Klinikleri" has no direct and/or indirect responsibility for any damage a third party suffered or will suffer regarding "USER"s actions on the "SITE" against the rules of the hereby "Terms of Use" and the law.

4.5. "USER"s accept and undertake that the information and context they provided to the "SITE" are accurate and legal. "Turkiye Klinikleri" is not liable and responsible for promising and guaranteeing the verification of the information and context transmitted to "Turkiye Klinikleri" by the "USER"s, or uploaded, changed and provided through the "SITE" by them and whether these information are safe, accurate and legal.

4.6. "USER"s agree and undertake that they will not perform any action leading to unfair competition, weakening the personal and commercial credit of "Turkiye Klinikleri" and a third party,  encroaching and attacking on personal rights within the "SITE" in accordance with the Turkish Commercial Code Law.

4.7. "Turkiye Klinikleri" reserves the right to change the services and the context within the "SITE"  anytime. "Turkiye Klinikleri" may use this right without any notification and timelessly. "USER"s have to make the changes and/or corrections "Turkiye Klinikleri" required immediately. Any changes and/or corrections that are required by "Turkiye Klinikleri", may be made by "Turkiye Klinikleri" when needed. Any harm, criminal and civil liability resulted or will result from changes and/or corrections required by "Turkiye Klinikleri" and were not made on time by the "USER"s belongs completely to the users.

4.8. "Turkiye Klinikleri" may give links through the "SITE" to other websites and/or "CONTEXT"s and/or folders that are outside of their control and owned and run by third parties. These links are provided for ease of reference only and do not hold qualification for support the respective web SITE or the admin or declaration or guarantee for the information inside. "Turkiye Klinikleri" does not hold any responsibility over the web-sites connected through the links on the "SITE", folders and context, the services or products on the websites provided through these links or their context.

4.9. "Turkiye Klinikleri" may use the information provided to them by the "USERS" through the "SITE" in line with the terms of the "PRIVACY POLICY" and "USER CONTRACT". It may process the information or classify and save them on a database. "Turkiye Klinikleri" may also use the USER's or visitor's identity, address, e-mail address, phone number, IP number, which sections of the "SITE" they visited, domain type, browser type, date and time information to provide statistical evaluation and customized services.

5. PROPRIETARY RIGHTS

5.1. The information accessed through this "SITE" or provided by the users legally and all the elements (including but not limited to design, text, image, html code and other codes) of the "SITE" (all of them will be called as studies tied to "Turkiye Klinikleri"s copyrights) belongs to "Turkiye Klinikleri". Users do not have the right to resell, process, share, distribute, display or give someone permission to access or to use the "Turkiye Klinikleri" services, "Turkiye Klinikleri" information and the products under copyright protection by "Turkiye Klinikleri". Within hereby "Terms of Use" unless explicitly permitted by "Turkiye Klinikleri" nobody can reproduce, process, distribute or produce or prepare any study from those under "Turkiye Klinikleri" copyright protection.

5.2. Within hereby "Terms of Use", "Turkiye Klinikleri" reserves the rights for "Turkiye Klinikleri" services, "Turkiye Klinikleri" information, the products associated with "Turkiye Klinikleri" copyrights, "Turkiye Klinikleri" trademarks, "Turkiye Klinikleri" trade looks or its all rights for other entity and information it has through this website unless it is explicitly authorized by "Turkiye Klinikleri".

6. CHANGES IN THE TERMS OF USE

"Turkiye Klinikleri" in its sole discretion may change the hereby "Terms of Use" anytime announcing within the "SITE". The changed terms of the hereby "Terms of Use" will become valid when they are announced. Hereby "Terms of Use" cannot be changed by unilateral declarations of users.

7. FORCE MAJEURE

"Turkiye Klinikleri" is not responsible for executing late or never of this hereby "Terms of Use", privacy policy and "USER Contract" in any situation legally taken into account as force majeure. Being late or failure of performance or non-defaulting of this and similar cases like this will not be the case from the viewpoint of "Turkiye Klinikleri", and "Turkiye Klinikleri" will not have any damage liability for these situations. "Force majeure" term will be regarded as outside of the concerned party's reasonable control and any situation that "Turkiye Klinikleri" cannot prevent even though it shows due diligence. Also, force majeure situations include but not limited to natural disasters, rebellion, war, strike, communication problems, infrastructure and internet failure, power cut and bad weather conditions.

8. LAW AND AUTHORISATION TO FOLLOW

Turkish Law will be applied in practicing, interpreting the hereby "Terms of Use" and managing the emerging legal relationships within this "Terms of Use" in case of finding element of foreignness, except for the rules of Turkish conflict of laws. Ankara Courts and Enforcement Offices are entitled in any controversy happened or may happen due to hereby contract.

9. CLOSING AND AGREEMENT

Hereby "Terms of Use" come into force when announced in the "SITE" by "Turkiye Klinikleri". The users are regarded to agree to hereby contract terms by using the "SITE". "Turkiye Klinikleri" may change the contract terms and the changes will be come into force by specifying the version number and the date of change on time it is published in the "SITE".

 

30.03.2014

Privacy Policy

We recommend you to read the terms of use below before you visit our website. In case you agree these terms, following our rules will be to your favor. Please read our Terms of Use thoroughly.

www.turkiyeklinikleri.com website belongs to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. and is designed in order to inform physicians in the field of health

www.turkiyeklinikleri.com cannot reach to user’s identity, address, service providers or other information. The users may send this information to the website through forms if they would like to. However, www.turkiyeklinikleri.com may collect your hardware and software information. The information consists of your IP address, browser type, operating system, domain name, access time, and related websites. www.turkiyeklinikleri.com cannot sell the provided user information (your name, e-mail address, home and work address, phone number) to the third parties, publish it publicly, or keep it in the website. Gathered information has a directing feature to be a source for the website’s visitor profile, reporting and promotion of the services.

www.turkiyeklinikleri.com uses the taken information:

-To enhance, improve and maintain the quality of the website

-To generate visitor’s profile and statistical data

-To determine the tendency of the visitors on using our website

-To send print publications/correspondences

-To send press releases or notifications through e-mail

-To generate a list for an event or competition

By using www.turkiyeklinikleri.com you are considered to agree that;

-Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. cannot be hold responsible for any user’s illegal and immoral behavior,

-Terms of use may change from time to time,

-It is not responsible for other websites’ contents it cannot control or the harms they may cause although it uses the connection they provided.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. may block the website to users in the following events:

-Information with wrong, incomplete, deceiving or immoral expressions is recorded to the website,

-Proclamation, advertisement, announcement, libelous expressions are used against natural person or legal identity,

-During various attacks to the website,

-Disruption of the website because of a virus.

Written, visual and audible materials of the website, including the code and the software are under protection by legal legislation.

Without the written consent of Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. the information on the website cannot be downloaded, changed, reproduced, copied, republished, posted or distributed.

All rights of the software and the design of the website belong to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. will be pleased to hear your comments about our terms of use. Please share the subjects you think may enrich our website or if there is any problem regarding our website.

info@turkiyeklinikleri.com